## Background: It has been suggested that cyclin-dependent kinase inhibitors (cdkis), including p16 and p15, are tumor suppressor genes. alterations of cdkis have been found in most types of cancer. however, little is known about the status of p16 and p15 genes, including methylation of the promote
✦ LIBER ✦
Inactivations of p16INK4a-α, p16INK4a-β and p15INK4b genes in 2′, 3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas
✍ Scribed by Zhuang, Shi-Mei; Schippert, Åsa; Haugen-Strano, Astrid; Wiseman, Roger W; Söderkvist, Peter
- Book ID
- 110061157
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 468 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Alterations of p16INK4A and p15INK4B gen
✍
Young Y. Lee; Shin H. Kang; Jin Y. Seo; Chul W. Jung; Kuhn U. Lee; Kuk J. Choe;
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 199 KB
👁 1 views
Influence of methylated p15 INK4b and p1
✍
Atsushi Ishiguro; Takenori Takahata; Masato Saito; Gen Yoshiya; Yoshihiro Tamura
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 187 KB
Deregulation of the tumour suppressor ge
✍
P. Kanellou; A. Zaravinos; M. Zioga; D.A. Spandidos
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 303 KB
Expression of p14ARF, p15INK4b, p16INK4a
✍
Zhang, Zhihong; Rosen, Daniel G; Yao, Jorge L; Huang, Jiaoti; Liu, Jinsong
📂
Article
📅
2006
🏛
Nature Publishing Group
🌐
English
⚖ 307 KB
Expression and regulation of G1 cell-cyc
✍
Schwaller, J; Pabst, Th; Koeffler, H P; Niklaus, G; Loetscher, P; Fey, M F; Tobl
📂
Article
📅
1997
🏛
Nature Publishing Group
🌐
English
⚖ 324 KB
Roles of p15Ink4b and p16Ink4a in myeloi
✍
Rose M. Ko; Hyung-Gyoon Kim; Linda Wolff; Christopher A. Klug
📂
Article
📅
2008
🏛
Elsevier Science
🌐
English
⚖ 967 KB
Inactivation of p15(Ink4b) expression by promoter hypermethylation occurs in up to 80% of acute myeloid leukemia (AML) cases and is particularly common in the FAB-M2 subtype of AML, which is characterized by the presence of the RUNX1-ETO translocation in 40% of cases. To establish whether the loss o